SMBG became available in the 1970s and enabled people with diabetes to perform an intensified insulin therapy by autonomously adjusting insulin doses to their lifestyle (e.g. flexibility regarding time and size of their meals and exercise), leading to improved glycaemic control and better health outcomes [11]. Here, INS is linked to diabetes mellitus.